p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up
- Authors
- Koo, So-My; Uh, Soo-taek; Kim, Dong Won; Kim, Ki-Up; Kim, Yang-Ki
- Issue Date
- Jun-2014
- Publisher
- 대한결핵및호흡기학회
- Keywords
- Mesothelioma; Tumor Suppressor Protein p53; Pleuragenetic
- Citation
- Tuberculosis and Respiratory Diseases, v.76, no.6, pp 284 - 288
- Pages
- 5
- Journal Title
- Tuberculosis and Respiratory Diseases
- Volume
- 76
- Number
- 6
- Start Page
- 284
- End Page
- 288
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/12169
- DOI
- 10.4046/trd.2014.76.6.284
- ISSN
- 1738-3536
2005-6184
- Abstract
- Malignant mesothelioma (MM) is the aggressive tumor of serosal surfaces. There are crude pathogenetic results regarding the biology of MM. Coordinated upregulations of p53 gene expression are shown in malignancies. We believed that there are changes in the p53 expression with transformation from reactive hyperplasia to MM. A 65-year-old male was admitted the hospital because of left pleuritic chest pains in 2004. Chest computed tomography (CT) results showed left pleural effusions with loculation and pleural thickening. Pathologic findings revealed reactive mesothelial hyperplasia. In 2008, the patient again felt left pleuritic chest pains. Chest CT showed progressive thickening of the left pleura. Pathologic diagnosis was atypical mesothelial hyperplasia. In 2011, chest CT showed progressive thickening of his left pleura. He was diagnosed with well-differentiated papillary mesothelioma. Serial change was analyzed by immunohistochemical staining for p53 of pleural tissues. There were no remarkable changes in p53 expressions during the transformation to MM.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.